This research report provides a comprehensive analysis of the Swine Influenza Vaccines market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Swine Influenza Vaccines market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Swine Influenza Vaccines, challenges faced by the industry, and potential opportunities for market players.
The global Swine Influenza Vaccines market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Swine Influenza Vaccines market presents opportunities for various stakeholders, including Commodity Pig, Breeding Pig. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Swine Influenza Vaccines market. Additionally, the growing consumer demand present avenues for market expansion.
The global Swine Influenza Vaccines market was valued at US$ 117 million in 2023 and is projected to reach US$ 159.9 million by 2030, at a CAGR of 4.5% during the forecast period.
The swine influenza vaccines market is experiencing significant growth due to the increasing prevalence of swine influenza and the rising demand for efficient disease prevention in swine populations. Swine influenza vaccines play a vital role in controlling and preventing respiratory diseases in pigs. The market is driven by factors such as the growth of the swine industry, the need for improved animal health and welfare, and the implementation of strict biosecurity measures. Advancements in vaccine development, including the availability of more effective and targeted vaccines, are further contributing to market growth. However, challenges such as the emergence of new strains of swine influenza virus and the requirement for periodic vaccine updates may impact market expansion. With the continuous focus on swine health management, disease prevention, and sustainable swine production, the swine influenza vaccines market is expected to witness sustained growth in the coming years.
Key Features:
The research report on the Swine Influenza Vaccines market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Swine Influenza Vaccines market.
Market Overview: The report provides a comprehensive overview of the Swine Influenza Vaccines market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Live Vaccines, Killed Vaccines), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Swine Influenza Vaccines market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Swine Influenza Vaccines market's trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Swine Influenza Vaccines market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Swine Influenza Vaccines market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Swine Influenza Vaccines market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Swine Influenza Vaccines market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Swine Influenza Vaccines, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Swine Influenza Vaccines market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
- Swine Influenza Vaccines market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
- Live Vaccines
- Killed Vaccines
Market segment by Application
- Commodity Pig
- Breeding Pig
Global Swine Influenza Vaccines Market Segment Percentages, By Region and Country, 2023 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Major players covered
- Chengdu TECBOND
- Green Cross Veterinary
- Hipra
- MSD Animal Health (Merck)
- Zoetis
- CAHIC
- Boehringer Ingelheim
- Ceva
- Ringpu Biology
- DHN
Outline of Major Chapters:
Chapter 1: Introduces the definition of Swine Influenza Vaccines, market overview.
Chapter 2: Global Swine Influenza Vaccines market size in revenue and volume.
Chapter 3: Detailed analysis of Swine Influenza Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments
by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments
by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Swine Influenza Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Swine Influenza Vaccines capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Swine Influenza Vaccines Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Swine Influenza Vaccines Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Swine Influenza Vaccines Overall Market Size
2.1 Global Swine Influenza Vaccines Market Size: 2023 VS 2030
2.2 Global Swine Influenza Vaccines Revenue, Prospects & Forecasts: 2019-2030
2.3 Global Swine Influenza Vaccines Sales: 2019-2030
3 Company Landscape
3.1 Top Swine Influenza Vaccines Players in Global Market
3.2 Top Global Swine Influenza Vaccines Companies Ranked by Revenue
3.3 Global Swine Influenza Vaccines Revenue by Companies
3.4 Global Swine Influenza Vaccines Sales by Companies
3.5 Global Swine Influenza Vaccines Price by Manufacturer (2019-2024)
3.6 Top 3 and Top 5 Swine Influenza Vaccines Companies in Global Market, by Revenue in 2023
3.7 Global Manufacturers Swine Influenza Vaccines Product Type
3.8 Tier 1, Tier 2 and Tier 3 Swine Influenza Vaccines Players in Global Market
3.8.1 List of Global Tier 1 Swine Influenza Vaccines Companies
3.8.2 List of Global Tier 2 and Tier 3 Swine Influenza Vaccines Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Swine Influenza Vaccines Market Size Markets, 2023 & 2030
4.1.2 Live Vaccines
4.1.3 Killed Vaccines
4.2 By Type - Global Swine Influenza Vaccines Revenue & Forecasts
4.2.1 By Type - Global Swine Influenza Vaccines Revenue, 2019-2024
4.2.2 By Type - Global Swine Influenza Vaccines Revenue, 2025-2030
4.2.3 By Type - Global Swine Influenza Vaccines Revenue Market Share, 2019-2030
4.3 By Type - Global Swine Influenza Vaccines Sales & Forecasts
4.3.1 By Type - Global Swine Influenza Vaccines Sales, 2019-2024
4.3.2 By Type - Global Swine Influenza Vaccines Sales, 2025-2030
4.3.3 By Type - Global Swine Influenza Vaccines Sales Market Share, 2019-2030
4.4 By Type - Global Swine Influenza Vaccines Price (Manufacturers Selling Prices), 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Swine Influenza Vaccines Market Size, 2023 & 2030
5.1.2 Commodity Pig
5.1.3 Breeding Pig
5.2 By Application - Global Swine Influenza Vaccines Revenue & Forecasts
5.2.1 By Application - Global Swine Influenza Vaccines Revenue, 2019-2024
5.2.2 By Application - Global Swine Influenza Vaccines Revenue, 2025-2030
5.2.3 By Application - Global Swine Influenza Vaccines Revenue Market Share, 2019-2030
5.3 By Application - Global Swine Influenza Vaccines Sales & Forecasts
5.3.1 By Application - Global Swine Influenza Vaccines Sales, 2019-2024
5.3.2 By Application - Global Swine Influenza Vaccines Sales, 2025-2030
5.3.3 By Application - Global Swine Influenza Vaccines Sales Market Share, 2019-2030
5.4 By Application - Global Swine Influenza Vaccines Price (Manufacturers Selling Prices), 2019-2030
6 Sights by Region
6.1 By Region - Global Swine Influenza Vaccines Market Size, 2023 & 2030
6.2 By Region - Global Swine Influenza Vaccines Revenue & Forecasts
6.2.1 By Region - Global Swine Influenza Vaccines Revenue, 2019-2024
6.2.2 By Region - Global Swine Influenza Vaccines Revenue, 2025-2030
6.2.3 By Region - Global Swine Influenza Vaccines Revenue Market Share, 2019-2030
6.3 By Region - Global Swine Influenza Vaccines Sales & Forecasts
6.3.1 By Region - Global Swine Influenza Vaccines Sales, 2019-2024
6.3.2 By Region - Global Swine Influenza Vaccines Sales, 2025-2030
6.3.3 By Region - Global Swine Influenza Vaccines Sales Market Share, 2019-2030
6.4 North America
6.4.1 By Country - North America Swine Influenza Vaccines Revenue, 2019-2030
6.4.2 By Country - North America Swine Influenza Vaccines Sales, 2019-2030
6.4.3 US Swine Influenza Vaccines Market Size, 2019-2030
6.4.4 Canada Swine Influenza Vaccines Market Size, 2019-2030
6.4.5 Mexico Swine Influenza Vaccines Market Size, 2019-2030
6.5 Europe
6.5.1 By Country - Europe Swine Influenza Vaccines Revenue, 2019-2030
6.5.2 By Country - Europe Swine Influenza Vaccines Sales, 2019-2030
6.5.3 Germany Swine Influenza Vaccines Market Size, 2019-2030
6.5.4 France Swine Influenza Vaccines Market Size, 2019-2030
6.5.5 U.K. Swine Influenza Vaccines Market Size, 2019-2030
6.5.6 Italy Swine Influenza Vaccines Market Size, 2019-2030
6.5.7 Russia Swine Influenza Vaccines Market Size, 2019-2030
6.5.8 Nordic Countries Swine Influenza Vaccines Market Size, 2019-2030
6.5.9 Benelux Swine Influenza Vaccines Market Size, 2019-2030
6.6 Asia
6.6.1 By Region - Asia Swine Influenza Vaccines Revenue, 2019-2030
6.6.2 By Region - Asia Swine Influenza Vaccines Sales, 2019-2030
6.6.3 China Swine Influenza Vaccines Market Size, 2019-2030
6.6.4 Japan Swine Influenza Vaccines Market Size, 2019-2030
6.6.5 South Korea Swine Influenza Vaccines Market Size, 2019-2030
6.6.6 Southeast Asia Swine Influenza Vaccines Market Size, 2019-2030
6.6.7 India Swine Influenza Vaccines Market Size, 2019-2030
6.7 South America
6.7.1 By Country - South America Swine Influenza Vaccines Revenue, 2019-2030
6.7.2 By Country - South America Swine Influenza Vaccines Sales, 2019-2030
6.7.3 Brazil Swine Influenza Vaccines Market Size, 2019-2030
6.7.4 Argentina Swine Influenza Vaccines Market Size, 2019-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Swine Influenza Vaccines Revenue, 2019-2030
6.8.2 By Country - Middle East & Africa Swine Influenza Vaccines Sales, 2019-2030
6.8.3 Turkey Swine Influenza Vaccines Market Size, 2019-2030
6.8.4 Israel Swine Influenza Vaccines Market Size, 2019-2030
6.8.5 Saudi Arabia Swine Influenza Vaccines Market Size, 2019-2030
6.8.6 UAE Swine Influenza Vaccines Market Size, 2019-2030
7 Manufacturers & Brands Profiles
7.1 Chengdu TECBOND
7.1.1 Chengdu TECBOND Company Summary
7.1.2 Chengdu TECBOND Business Overview
7.1.3 Chengdu TECBOND Swine Influenza Vaccines Major Product Offerings
7.1.4 Chengdu TECBOND Swine Influenza Vaccines Sales and Revenue in Global (2019-2024)
7.1.5 Chengdu TECBOND Key News & Latest Developments
7.2 Green Cross Veterinary
7.2.1 Green Cross Veterinary Company Summary
7.2.2 Green Cross Veterinary Business Overview
7.2.3 Green Cross Veterinary Swine Influenza Vaccines Major Product Offerings
7.2.4 Green Cross Veterinary Swine Influenza Vaccines Sales and Revenue in Global (2019-2024)
7.2.5 Green Cross Veterinary Key News & Latest Developments
7.3 Hipra
7.3.1 Hipra Company Summary
7.3.2 Hipra Business Overview
7.3.3 Hipra Swine Influenza Vaccines Major Product Offerings
7.3.4 Hipra Swine Influenza Vaccines Sales and Revenue in Global (2019-2024)
7.3.5 Hipra Key News & Latest Developments
7.4 MSD Animal Health (Merck)
7.4.1 MSD Animal Health (Merck) Company Summary
7.4.2 MSD Animal Health (Merck) Business Overview
7.4.3 MSD Animal Health (Merck) Swine Influenza Vaccines Major Product Offerings
7.4.4 MSD Animal Health (Merck) Swine Influenza Vaccines Sales and Revenue in Global (2019-2024)
7.4.5 MSD Animal Health (Merck) Key News & Latest Developments
7.5 Zoetis
7.5.1 Zoetis Company Summary
7.5.2 Zoetis Business Overview
7.5.3 Zoetis Swine Influenza Vaccines Major Product Offerings
7.5.4 Zoetis Swine Influenza Vaccines Sales and Revenue in Global (2019-2024)
7.5.5 Zoetis Key News & Latest Developments
7.6 CAHIC
7.6.1 CAHIC Company Summary
7.6.2 CAHIC Business Overview
7.6.3 CAHIC Swine Influenza Vaccines Major Product Offerings
7.6.4 CAHIC Swine Influenza Vaccines Sales and Revenue in Global (2019-2024)
7.6.5 CAHIC Key News & Latest Developments
7.7 Boehringer Ingelheim
7.7.1 Boehringer Ingelheim Company Summary
7.7.2 Boehringer Ingelheim Business Overview
7.7.3 Boehringer Ingelheim Swine Influenza Vaccines Major Product Offerings
7.7.4 Boehringer Ingelheim Swine Influenza Vaccines Sales and Revenue in Global (2019-2024)
7.7.5 Boehringer Ingelheim Key News & Latest Developments
7.8 Ceva
7.8.1 Ceva Company Summary
7.8.2 Ceva Business Overview
7.8.3 Ceva Swine Influenza Vaccines Major Product Offerings
7.8.4 Ceva Swine Influenza Vaccines Sales and Revenue in Global (2019-2024)
7.8.5 Ceva Key News & Latest Developments
7.9 Ringpu Biology
7.9.1 Ringpu Biology Company Summary
7.9.2 Ringpu Biology Business Overview
7.9.3 Ringpu Biology Swine Influenza Vaccines Major Product Offerings
7.9.4 Ringpu Biology Swine Influenza Vaccines Sales and Revenue in Global (2019-2024)
7.9.5 Ringpu Biology Key News & Latest Developments
7.10 DHN
7.10.1 DHN Company Summary
7.10.2 DHN Business Overview
7.10.3 DHN Swine Influenza Vaccines Major Product Offerings
7.10.4 DHN Swine Influenza Vaccines Sales and Revenue in Global (2019-2024)
7.10.5 DHN Key News & Latest Developments
8 Global Swine Influenza Vaccines Production Capacity, Analysis
8.1 Global Swine Influenza Vaccines Production Capacity, 2019-2030
8.2 Swine Influenza Vaccines Production Capacity of Key Manufacturers in Global Market
8.3 Global Swine Influenza Vaccines Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Swine Influenza Vaccines Supply Chain Analysis
10.1 Swine Influenza Vaccines Industry Value Chain
10.2 Swine Influenza Vaccines Upstream Market
10.3 Swine Influenza Vaccines Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Swine Influenza Vaccines Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Swine Influenza Vaccines in Global Market
Table 2. Top Swine Influenza Vaccines Players in Global Market, Ranking by Revenue (2023)
Table 3. Global Swine Influenza Vaccines Revenue by Companies, (US$, Mn), 2019-2024
Table 4. Global Swine Influenza Vaccines Revenue Share by Companies, 2019-2024
Table 5. Global Swine Influenza Vaccines Sales by Companies, (M Units), 2019-2024
Table 6. Global Swine Influenza Vaccines Sales Share by Companies, 2019-2024
Table 7. Key Manufacturers Swine Influenza Vaccines Price (2019-2024) & (USD/K Unit)
Table 8. Global Manufacturers Swine Influenza Vaccines Product Type
Table 9. List of Global Tier 1 Swine Influenza Vaccines Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Swine Influenza Vaccines Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Swine Influenza Vaccines Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Global Swine Influenza Vaccines Revenue (US$, Mn), 2019-2024
Table 13. By Type - Global Swine Influenza Vaccines Revenue (US$, Mn), 2025-2030
Table 14. By Type - Global Swine Influenza Vaccines Sales (M Units), 2019-2024
Table 15. By Type - Global Swine Influenza Vaccines Sales (M Units), 2025-2030
Table 16. By Application ? Global Swine Influenza Vaccines Revenue, (US$, Mn), 2023 & 2030
Table 17. By Application - Global Swine Influenza Vaccines Revenue (US$, Mn), 2019-2024
Table 18. By Application - Global Swine Influenza Vaccines Revenue (US$, Mn), 2025-2030
Table 19. By Application - Global Swine Influenza Vaccines Sales (M Units), 2019-2024
Table 20. By Application - Global Swine Influenza Vaccines Sales (M Units), 2025-2030
Table 21. By Region ? Global Swine Influenza Vaccines Revenue, (US$, Mn), 2023 VS 2030
Table 22. By Region - Global Swine Influenza Vaccines Revenue (US$, Mn), 2019-2024
Table 23. By Region - Global Swine Influenza Vaccines Revenue (US$, Mn), 2025-2030
Table 24. By Region - Global Swine Influenza Vaccines Sales (M Units), 2019-2024
Table 25. By Region - Global Swine Influenza Vaccines Sales (M Units), 2025-2030
Table 26. By Country - North America Swine Influenza Vaccines Revenue, (US$, Mn), 2019-2024
Table 27. By Country - North America Swine Influenza Vaccines Revenue, (US$, Mn), 2025-2030
Table 28. By Country - North America Swine Influenza Vaccines Sales, (M Units), 2019-2024
Table 29. By Country - North America Swine Influenza Vaccines Sales, (M Units), 2025-2030
Table 30. By Country - Europe Swine Influenza Vaccines Revenue, (US$, Mn), 2019-2024
Table 31. By Country - Europe Swine Influenza Vaccines Revenue, (US$, Mn), 2025-2030
Table 32. By Country - Europe Swine Influenza Vaccines Sales, (M Units), 2019-2024
Table 33. By Country - Europe Swine Influenza Vaccines Sales, (M Units), 2025-2030
Table 34. By Region - Asia Swine Influenza Vaccines Revenue, (US$, Mn), 2019-2024
Table 35. By Region - Asia Swine Influenza Vaccines Revenue, (US$, Mn), 2025-2030
Table 36. By Region - Asia Swine Influenza Vaccines Sales, (M Units), 2019-2024
Table 37. By Region - Asia Swine Influenza Vaccines Sales, (M Units), 2025-2030
Table 38. By Country - South America Swine Influenza Vaccines Revenue, (US$, Mn), 2019-2024
Table 39. By Country - South America Swine Influenza Vaccines Revenue, (US$, Mn), 2025-2030
Table 40. By Country - South America Swine Influenza Vaccines Sales, (M Units), 2019-2024
Table 41. By Country - South America Swine Influenza Vaccines Sales, (M Units), 2025-2030
Table 42. By Country - Middle East & Africa Swine Influenza Vaccines Revenue, (US$, Mn), 2019-2024
Table 43. By Country - Middle East & Africa Swine Influenza Vaccines Revenue, (US$, Mn), 2025-2030
Table 44. By Country - Middle East & Africa Swine Influenza Vaccines Sales, (M Units), 2019-2024
Table 45. By Country - Middle East & Africa Swine Influenza Vaccines Sales, (M Units), 2025-2030
Table 46. Chengdu TECBOND Company Summary
Table 47. Chengdu TECBOND Swine Influenza Vaccines Product Offerings
Table 48. Chengdu TECBOND Swine Influenza Vaccines Sales (M Units), Revenue (US$, Mn) and Average Price (USD/K Unit) (2019-2024)
Table 49. Chengdu TECBOND Key News & Latest Developments
Table 50. Green Cross Veterinary Company Summary
Table 51. Green Cross Veterinary Swine Influenza Vaccines Product Offerings
Table 52. Green Cross Veterinary Swine Influenza Vaccines Sales (M Units), Revenue (US$, Mn) and Average Price (USD/K Unit) (2019-2024)
Table 53. Green Cross Veterinary Key News & Latest Developments
Table 54. Hipra Company Summary
Table 55. Hipra Swine Influenza Vaccines Product Offerings
Table 56. Hipra Swine Influenza Vaccines Sales (M Units), Revenue (US$, Mn) and Average Price (USD/K Unit) (2019-2024)
Table 57. Hipra Key News & Latest Developments
Table 58. MSD Animal Health (Merck) Company Summary
Table 59. MSD Animal Health (Merck) Swine Influenza Vaccines Product Offerings
Table 60. MSD Animal Health (Merck) Swine Influenza Vaccines Sales (M Units), Revenue (US$, Mn) and Average Price (USD/K Unit) (2019-2024)
Table 61. MSD Animal Health (Merck) Key News & Latest Developments
Table 62. Zoetis Company Summary
Table 63. Zoetis Swine Influenza Vaccines Product Offerings
Table 64. Zoetis Swine Influenza Vaccines Sales (M Units), Revenue (US$, Mn) and Average Price (USD/K Unit) (2019-2024)
Table 65. Zoetis Key News & Latest Developments
Table 66. CAHIC Company Summary
Table 67. CAHIC Swine Influenza Vaccines Product Offerings
Table 68. CAHIC Swine Influenza Vaccines Sales (M Units), Revenue (US$, Mn) and Average Price (USD/K Unit) (2019-2024)
Table 69. CAHIC Key News & Latest Developments
Table 70. Boehringer Ingelheim Company Summary
Table 71. Boehringer Ingelheim Swine Influenza Vaccines Product Offerings
Table 72. Boehringer Ingelheim Swine Influenza Vaccines Sales (M Units), Revenue (US$, Mn) and Average Price (USD/K Unit) (2019-2024)
Table 73. Boehringer Ingelheim Key News & Latest Developments
Table 74. Ceva Company Summary
Table 75. Ceva Swine Influenza Vaccines Product Offerings
Table 76. Ceva Swine Influenza Vaccines Sales (M Units), Revenue (US$, Mn) and Average Price (USD/K Unit) (2019-2024)
Table 77. Ceva Key News & Latest Developments
Table 78. Ringpu Biology Company Summary
Table 79. Ringpu Biology Swine Influenza Vaccines Product Offerings
Table 80. Ringpu Biology Swine Influenza Vaccines Sales (M Units), Revenue (US$, Mn) and Average Price (USD/K Unit) (2019-2024)
Table 81. Ringpu Biology Key News & Latest Developments
Table 82. DHN Company Summary
Table 83. DHN Swine Influenza Vaccines Product Offerings
Table 84. DHN Swine Influenza Vaccines Sales (M Units), Revenue (US$, Mn) and Average Price (USD/K Unit) (2019-2024)
Table 85. DHN Key News & Latest Developments
Table 86. Swine Influenza Vaccines Production Capacity (M Units) of Key Manufacturers in Global Market, 2022-2024 (M Units)
Table 87. Global Swine Influenza Vaccines Capacity Market Share of Key Manufacturers, 2022-2024
Table 88. Global Swine Influenza Vaccines Production by Region, 2019-2024 (M Units)
Table 89. Global Swine Influenza Vaccines Production by Region, 2025-2030 (M Units)
Table 90. Swine Influenza Vaccines Market Opportunities & Trends in Global Market
Table 91. Swine Influenza Vaccines Market Drivers in Global Market
Table 92. Swine Influenza Vaccines Market Restraints in Global Market
Table 93. Swine Influenza Vaccines Raw Materials
Table 94. Swine Influenza Vaccines Raw Materials Suppliers in Global Market
Table 95. Typical Swine Influenza Vaccines Downstream
Table 96. Swine Influenza Vaccines Downstream Clients in Global Market
Table 97. Swine Influenza Vaccines Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Swine Influenza Vaccines Segment by Type in 2023
Figure 2. Swine Influenza Vaccines Segment by Application in 2023
Figure 3. Global Swine Influenza Vaccines Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Swine Influenza Vaccines Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Swine Influenza Vaccines Revenue, 2019-2030 (US$, Mn)
Figure 7. Swine Influenza Vaccines Sales in Global Market: 2019-2030 (M Units)
Figure 8. The Top 3 and 5 Players Market Share by Swine Influenza Vaccines Revenue in 2023
Figure 9. By Type - Global Swine Influenza Vaccines Revenue, (US$, Mn), 2023 & 2030
Figure 10. By Type - Global Swine Influenza Vaccines Revenue Market Share, 2019-2030
Figure 11. By Type - Global Swine Influenza Vaccines Sales Market Share, 2019-2030
Figure 12. By Type - Global Swine Influenza Vaccines Price (USD/K Unit), 2019-2030
Figure 13. By Application - Global Swine Influenza Vaccines Revenue, (US$, Mn), 2023 & 2030
Figure 14. By Application - Global Swine Influenza Vaccines Revenue Market Share, 2019-2030
Figure 15. By Application - Global Swine Influenza Vaccines Sales Market Share, 2019-2030
Figure 16. By Application - Global Swine Influenza Vaccines Price (USD/K Unit), 2019-2030
Figure 17. By Region - Global Swine Influenza Vaccines Revenue, (US$, Mn), 2023 & 2030
Figure 18. By Region - Global Swine Influenza Vaccines Revenue Market Share, 2019 VS 2023 VS 2030
Figure 19. By Region - Global Swine Influenza Vaccines Revenue Market Share, 2019-2030
Figure 20. By Region - Global Swine Influenza Vaccines Sales Market Share, 2019-2030
Figure 21. By Country - North America Swine Influenza Vaccines Revenue Market Share, 2019-2030
Figure 22. By Country - North America Swine Influenza Vaccines Sales Market Share, 2019-2030
Figure 23. US Swine Influenza Vaccines Revenue, (US$, Mn), 2019-2030
Figure 24. Canada Swine Influenza Vaccines Revenue, (US$, Mn), 2019-2030
Figure 25. Mexico Swine Influenza Vaccines Revenue, (US$, Mn), 2019-2030
Figure 26. By Country - Europe Swine Influenza Vaccines Revenue Market Share, 2019-2030
Figure 27. By Country - Europe Swine Influenza Vaccines Sales Market Share, 2019-2030
Figure 28. Germany Swine Influenza Vaccines Revenue, (US$, Mn), 2019-2030
Figure 29. France Swine Influenza Vaccines Revenue, (US$, Mn), 2019-2030
Figure 30. U.K. Swine Influenza Vaccines Revenue, (US$, Mn), 2019-2030
Figure 31. Italy Swine Influenza Vaccines Revenue, (US$, Mn), 2019-2030
Figure 32. Russia Swine Influenza Vaccines Revenue, (US$, Mn), 2019-2030
Figure 33. Nordic Countries Swine Influenza Vaccines Revenue, (US$, Mn), 2019-2030
Figure 34. Benelux Swine Influenza Vaccines Revenue, (US$, Mn), 2019-2030
Figure 35. By Region - Asia Swine Influenza Vaccines Revenue Market Share, 2019-2030
Figure 36. By Region - Asia Swine Influenza Vaccines Sales Market Share, 2019-2030
Figure 37. China Swine Influenza Vaccines Revenue, (US$, Mn), 2019-2030
Figure 38. Japan Swine Influenza Vaccines Revenue, (US$, Mn), 2019-2030
Figure 39. South Korea Swine Influenza Vaccines Revenue, (US$, Mn), 2019-2030
Figure 40. Southeast Asia Swine Influenza Vaccines Revenue, (US$, Mn), 2019-2030
Figure 41. India Swine Influenza Vaccines Revenue, (US$, Mn), 2019-2030
Figure 42. By Country - South America Swine Influenza Vaccines Revenue Market Share, 2019-2030
Figure 43. By Country - South America Swine Influenza Vaccines Sales Market Share, 2019-2030
Figure 44. Brazil Swine Influenza Vaccines Revenue, (US$, Mn), 2019-2030
Figure 45. Argentina Swine Influenza Vaccines Revenue, (US$, Mn), 2019-2030
Figure 46. By Country - Middle East & Africa Swine Influenza Vaccines Revenue Market Share, 2019-2030
Figure 47. By Country - Middle East & Africa Swine Influenza Vaccines Sales Market Share, 2019-2030
Figure 48. Turkey Swine Influenza Vaccines Revenue, (US$, Mn), 2019-2030
Figure 49. Israel Swine Influenza Vaccines Revenue, (US$, Mn), 2019-2030
Figure 50. Saudi Arabia Swine Influenza Vaccines Revenue, (US$, Mn), 2019-2030
Figure 51. UAE Swine Influenza Vaccines Revenue, (US$, Mn), 2019-2030
Figure 52. Global Swine Influenza Vaccines Production Capacity (M Units), 2019-2030
Figure 53. The Percentage of Production Swine Influenza Vaccines by Region, 2023 VS 2030
Figure 54. Swine Influenza Vaccines Industry Value Chain
Figure 55. Marketing Channels
